HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 357 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $223,279 | +5.4% | 5,845 | -0.5% | 0.00% | 0.0% |
| Q2 2023 | $211,875 | +98907.0% | 5,874 | +5.0% | 0.00% | 0.0% |
| Q1 2023 | $214 | -44.1% | 5,593 | -16.8% | 0.00% | -33.3% |
| Q4 2022 | $383 | -99.9% | 6,723 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $300,000 | +0.3% | 6,723 | -1.0% | 0.00% | 0.0% |
| Q2 2022 | $299,000 | +10.3% | 6,791 | 0.0% | 0.00% | +50.0% |
| Q1 2022 | $271,000 | +35.5% | 6,791 | +17.7% | 0.00% | +100.0% |
| Q4 2021 | $200,000 | -18.0% | 5,771 | -4.0% | 0.00% | 0.0% |
| Q3 2021 | $244,000 | -51.3% | 6,010 | -45.5% | 0.00% | -66.7% |
| Q2 2021 | $501,000 | +8.9% | 11,037 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $460,000 | -2.3% | 11,037 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $471,000 | +141.5% | 11,037 | +48.9% | 0.00% | +50.0% |
| Q3 2020 | $195,000 | -53.2% | 7,413 | -52.4% | 0.00% | -50.0% |
| Q2 2020 | $417,000 | +89.5% | 15,567 | +27.4% | 0.00% | +100.0% |
| Q1 2020 | $220,000 | -31.7% | 12,220 | -32.7% | 0.00% | -33.3% |
| Q4 2019 | $322,000 | +22.0% | 18,150 | +6.6% | 0.00% | +50.0% |
| Q3 2019 | $264,000 | +172.2% | 17,030 | +202.5% | 0.00% | +100.0% |
| Q2 2019 | $97,000 | +6.6% | 5,630 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $91,000 | +11.0% | 5,630 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $82,000 | -19.6% | 5,630 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $102,000 | +5.2% | 5,630 | -2.4% | 0.00% | 0.0% |
| Q2 2018 | $97,000 | -14.2% | 5,770 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $113,000 | -8.9% | 5,770 | -5.7% | 0.00% | 0.0% |
| Q4 2017 | $124,000 | +17.0% | 6,120 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $106,000 | +35.9% | 6,120 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $78,000 | -1.3% | 6,120 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $79,000 | +12.9% | 6,120 | -13.8% | 0.00% | 0.0% |
| Q4 2016 | $70,000 | +180.0% | 7,100 | +238.1% | 0.00% | – |
| Q3 2016 | $25,000 | +212.5% | 2,100 | +133.3% | 0.00% | – |
| Q2 2016 | $8,000 | -11.1% | 900 | 0.0% | 0.00% | – |
| Q1 2016 | $9,000 | – | 900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 7,048,282 | $126,799,000 | 27.23% |
| First Light Asset Management, LLC | 1,630,591 | $29,334,000 | 5.01% |
| SNYDER CAPITAL MANAGEMENT L P | 3,393,057 | $61,041,000 | 3.48% |
| Bellevue Group AG | 7,663,956 | $137,874,000 | 2.67% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 307,633 | $5,531,000 | 2.52% |
| Lombard Odier Asset Management (Switzerland) SA | 900,000 | $16,191,000 | 2.17% |
| Elk Creek Partners, LLC | 654,362 | $11,772,000 | 2.02% |
| DOHENY ASSET MANAGEMENT /CA | 127,110 | $2,254,000 | 1.79% |
| Granite Investment Partners, LLC | 1,277,438 | $22,981,000 | 1.49% |
| Amia Capital LLP | 69,409 | $1,249,000 | 1.11% |